Opendata, web and dolomites

MAP-Detector

Development of a novel low dose, high resolution, high contrast X-ray detector for medical applications to improve patient diagnoses and reduce the risk of X-radiation induced cancer

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MAP-Detector project word cloud

Explore the words cloud of the MAP-Detector project. It provides you a very rough idea of what is the project "MAP-Detector" about.

whilst    rapid    market    clinical    13    cadmium    significantly    enhanced    drafting    radiation    trials    4bn    mammography    reduce    accounted    patients    solutions    earlier    technique    telluride    leverage    2017    manufacturers    discrimination    2012    1bn       superior    intend    offers    segments    showing    latter    gt    risk    industry    detector    global    detectors    patented    fluoroscopy    countries    seeking    valuable    21       plan    initial    diagnostic    thoroughly    material    retrofitted    ct    materials    conduct    certification    incorporating    treatment    dose       share    detection    50    0bn    requirement    ray    culminate    27    introduction    grow    plus    innovative    medical    segment    ibex    preparation    surpasses    inspection    former    47    route    disruptive    dosage    accounting    cdte    plate    cancer    imaging    map    exposes    absorption    keenly    business    exposure    compatible    2011   

Project "MAP-Detector" data sheet

The following table provides information about the project.

Coordinator
IBEX INNOVATIONS LTD 

Organization address
address: DISCOVERY 2 NETPARK
city: SEDGEFIELD
postcode: TS21 3FH
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.ibexinnovations.co.uk
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-05-01   to  2015-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    IBEX INNOVATIONS LTD UK (SEDGEFIELD) coordinator 50˙000.00

Map

 Project objective

X-ray imaging is a valuable medical diagnostic technique, accounting for 47% of the medical imaging market in 2011. However, current X-ray detection technology exposes patients to increased risk of developing cancer with research in 13 developing countries showing that exposure to X-ray detection technology accounted for 0•6% to 1•8% of the cancer cases. X-ray detector manufacturers are thus keenly seeking technology that would reduce radiation exposure (dose) to patients whilst offering superior material discrimination for earlier detection and treatment of clinical cases. As IBEX, we have developed and patented an innovative X-ray detection technology incorporating our unique Multi Absorption Plate (MAP). Our technology significantly surpasses current solutions based on cadmium telluride (CdTe) as it offers potential dose reduction of >50% plus enhanced materials discrimination. MAP-Detector offers a disruptive X-ray detector that will leverage the MAP technology in both retrofitted and new build X-ray detectors for medical applications. The global medical diagnostic imaging market is expected to grow from €21.4bn in 2012 to €27.4bn by 2017, with X-ray and CT imaging equipment having a 50%/€13.1bn share in 2017. Within this segment, the X-ray imaging detector market is estimated at €2.0bn. Our technology will be compatible with the leading X-ray inspection systems creating significant market potential. Our initial target segments within the medical industry are fluoroscopy and mammography with dosage reduction being far more important for the former and materials discrimination an essential requirement for the latter. In Phase 1 we will thoroughly analyse the market to more clearly define our route to market and requirements for rapid market uptake. This will culminate in the drafting of a more detailed operational business plan. In Phase 2 we intend to conduct clinical trials and achieve certification for our technology in preparation for market introduction.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MAP-DETECTOR" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MAP-DETECTOR" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More  

ESCALON (2019)

European-Latin American network for the assessment of biomarkers to predict and diagnose hepatobiliary malignancies and characterization of risk factors for cancer development

Read More  

PREFERABLE (2019)

Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life

Read More